53426 Federal Register / Vol. 73, No. 180 / Tuesday, September 16, 2008 / Notices 

1843) (BHC Act) and Regulation Y (12 

CFR Part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. Additional information on all 

bank holding companies may be 

obtained from the National Information 

Center website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors 

not later than October 1, 2008. 

A. Federal Reserve Bank of New 

York (Anne MacEwen, Bank 

Applications Officer) 33 Liberty Street, 

New York, New York 10045–0001: 

1. EuroBancshares, Inc., to engage de 

novo through its subsidiary, EUBK 

Securities, Inc. (in formation), both of 

San Juan, Puerto Rico, in securities 

brokerage, riskless principal 

transactions, and other transactional 

services, pursuant to sections 

225.28(b)(7)(i), (ii) and (v) of Regulation 

Y. 

B. Federal Reserve Bank of Atlanta 

(Steve Foley, Vice President) 1000 

Peachtree Street, N.E., Atlanta, Georgia 

30309: 

1. Commerce Bancshares Inc., 

Franklin, Tennessee, to engage de novo 

in management consulting activities, 

pursuant to section 225.28(b)(9)(ii) of 

Regulation Y. 

C. Federal Reserve Bank of Kansas 

City (Todd Offenbacker, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. CLC Enterprises, Inc., Nelson, 

Nebraska, to engage de novo in lending 

activities, pursuant to section 

225.28(b)(1) of Regulation Y. 

Board of Governors of the Federal Reserve 

System, September 11, 2008. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. E8–21593 Filed 9–15–08; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Renewal of Charter for the Chronic 

Fatigue Syndrome Advisory 

Committee 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of Public Health and Science. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, as amended (5 

U.S.C. Appendix 2), the U.S. 

Department of Health and Human 

Services is hereby announcing renewal 

of the charter for the Chronic Fatigue 

Syndrome Advisory Committee 

(CFSAC). 

FOR FURTHER INFORMATION CONTACT: Dr. 

Anand K. Parekh, Executive Secretary, 

Chronic Fatigue Syndrome Advisory 

Committee, Department of Health and 

Human Services, 200 Independence 

Avenue, SW., Room 727H, Washington, 

DC 20201; (202) 401–7605. 

SUPPLEMENTARY INFORMATION: CFSAC 

was established on September 5, 2002. 

The Committee was established to 

advise, consult with, and make 

recommendations to the Secretary, 

through the Assistant Secretary for 

Health, on a broad range of topics 

including (1) The current state of 

knowledge and research about the 

epidemiology and risk factors relating to 

chronic fatigue syndrome, and 

identifying potential opportunities in 

these areas; (2) current and proposed 

diagnosis and treatment methods for 

chronic fatigue syndrome; and (3) 

development and implementation of 

programs to inform the public, health 

care professionals, and the biomedical, 

academic, and research communities 

about chronic fatigue syndrome 

advances. 

Since CFSAC was established, 

renewal of the Committee charter has 

been carried out at the appropriate 

intervals as stipulated by FACA. The 

previous Committee charter was 

scheduled to expire on September 5, 

2008. On August 27, 2008, the Secretary 

of Health and Human Services approved 

for the Committee charter to be 

renewed. Renewal of the CFSAC charter 

provides authorization for the 

Committee to operate until September 5, 

2010. A copy of the Committee charter 

is available on the CFSAC Web site at 

http://www.hhs.gov/advcomcfs. A copy 

of the Committee charter also can be 

obtained by accessing the FACA 

database that is maintained by the 

Committee Management Secretariat 

under the General Services 

Administration. The Web site address 

for the FACA database is http://fido.gov/ 

facadatabase. 

Dated: September 10, 2008. 

Anand K. Parekh, 

Executive Secretary, Chronic Fatigue 

Syndrome Advisory Committee. 

[FR Doc. E8–21516 Filed 9–15–08; 8:45 am] 

BILLING CODE 4150–42–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS); Notice of Meeting 

Classifications and Public Health Data 

Standards Staff, announces the 

following meeting: 

Name: ICD–9–CM Coordination and 

Maintenance Committee meeting. 

Times and Dates: 8:30 a.m.–6 p.m.., 

September 24, 2008. 8:30 a.m.–6 p.m., 

September 25, 2008. 

Place: Centers for Medicare and 

Medicaid Services (CMS) Auditorium, 

7500 Security Boulevard, Baltimore, 

Maryland. 

Status: Open to the public. 

Purpose: The ICD–9–CM Coordination 

and Maintenance (C&M) Committee will 

hold its first meeting of the 2008 

calendar year cycle on Wednesday and 

Thursday September 24–25, 2008. The 

C&M meeting is a public forum for the 

presentation of proposed modifications 

to the International Classification of 

Diseases, Ninth-Revision, Clinical 

Modification. 

Matters to be Discussed: Tentative 

agenda items include: 

Activity codes 

Acute Life Threatening Event (ALTE) 

Colic 

Congestive heart failure 

Dysphonia 

Endometrial intraepithelial neoplasia 

Epilepsy 

Failed sedation 

Fitting/adjustment, gastric band 

Fluency disorders 

Gout 

Merkel cell carcinoma 

Pouchitis 

Sleep maintenance 

Traumatic brain injury 

Tumor lysis syndrome 

Venous thrombosis embolism 

Addenda (diagnoses) 

Cardiac contractility modulation 

Endoscopic insertion of colonic stent 

Endoscopic valve insertion 

Infrared vascular imaging 

Intraoperative Anesthetic Effect 

Monitoring and Titration 

Intravitreal injectables 


ebenthall on PROD1PC60 with NOTICES